Collectively, the analysis of the effect of expression of PAPP‐A both in vitro and in vivo suggests that PAPP‐A is a pregnancy‐dependent oncogene that promotes the formation of mammary tumors characterized by a TACS‐3 signature and low IGFBP‐5 levels. The gene discussed is PAPPA; the disease is breast cancer.